We are live on ! Find out more
ACTU

Actuate Therapeutics
ACTU

43 hedge funds and large institutions have $80.5M invested in Actuate Therapeutics in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5.43% less ownership

Funds ownership: 57.17% → 51.74% (-5.4%)

Holders
43
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.42M
2
+$628K
3
+$616K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$374K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$198K

Top Sellers

1
-$206K
2
-$154K
3
-$79.7K
4
Bank of America
Bank of America
North Carolina
-$75.5K
5
CPIG
Chicago Partners Investment Group
Illinois
-$68.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$16.6K
27
$11K
28
$10.4K
29
$8.44K
30
$8.42K
31
$5.92K
32
$4.74K
33
$4.02K
34
$3.83K
35
$3.26K
36
$2.57K
37
$2.46K
38
$1.74K
39
$1K
40
$469
41
$401
42
$100
43
–
44
–
45
–
1
2